Altered Dermal Fibroblasts in Systemic Sclerosis Display Podoplanin and CD90
- 1 October 2016
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 186 (10) , 2650-2664
Abstract
No abstract availableKeywords
Funding Information
- NIH Clinical & Translational Science Institute (UL1-TR000157)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (5P30AR061271, 1P50AR060780, 2R01AR051089)
This publication has 80 references indexed in Scilit:
- Mechanisms of fibrosis: therapeutic translation for fibrotic diseaseNature Medicine, 2012
- Podoplanin: emerging functions in development, the immune system, and cancerFrontiers in Immunology, 2012
- The Tunica Adventitia of Human Arteries and Veins As a Source of Mesenchymal Stem CellsStem Cells and Development, 2011
- The tumor necrosis factor family member LIGHT is a target for asthmatic airway remodelingNature Medicine, 2011
- Association of T-Zone Reticular Networks and Conduits with Ectopic Lymphoid Tissues in Mice and HumansThe American Journal of Pathology, 2011
- The tumour-associated glycoprotein podoplanin is expressed in fibroblast-like synoviocytes of the hyperplastic synovial lining layer in rheumatoid arthritisArthritis Research & Therapy, 2011
- Poly(I:C) Drives Type I IFN- and TGFβ-Mediated Inflammation and Dermal Fibrosis Simulating Altered Gene Expression in Systemic SclerosisJournal of Investigative Dermatology, 2010
- Thy-1-Integrin αvβ5 Interactions Inhibit Lung Fibroblast Contraction-induced Latent Transforming Growth Factor-β1 Activation and Myofibroblast DifferentiationJournal of Biological Chemistry, 2010
- Lymphatic and blood vessels in scleroderma skin, a morphometric analysisHuman Pathology, 2010
- Molecular Subsets in the Gene Expression Signatures of Scleroderma SkinPLOS ONE, 2008